Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study

Table 4 Outcomes of patients colonized with VRE compared with those of controls

	Total (n = 166)		Cases. n = 83 (50%)		Controls. n = 83 (50%)		p-value
VRE infection	11 (6.6)		11 (13.3)		0 (0.0)		0.001
BSI	8 (4.8)		8 (9.6)		0 (0.0)
UTI	2 (1.2)		2 (2.4)		0 (0.0)
IAI	1 (0.6)		1 (1.2)		0 (0.0)
No VRE infection	155 (93.4)		72 (86.7)		83 (100.0)
Time from VRE colonization to VRE infection days, mean\(\pm\)SD (range)			30.2, 26.8(0–72)
CDI	8 (4.8)		7 (8.4)		1 (1.2)		0.030
30-day mortality, *n/N (%)*
Overall *		10/166 (6.0)		4 (4.8)		6 (7.2)		0.514
VRE infection		0/11 (0.0)		0/11 (0.0)		0/0 (0.0)		-
No VRE infection		10/155 (6.4)		4/72 (5.6)		6/83 (7.2)		0.672
90-day mortality, *n/N (%)*		20 /166 (12.0)		8 (9.6)		12 (14.5)		0.340

VRE: vancomycin resistant Enterococcus, BSI: bloodstream infection, UTI: urinary tract infection, IAI: intra-abdominal infection, CDI: Clostridioides difficile infection
*comparison between 30 day mortality of cases with or without VRE infection, p_0.448

ISSN: 2047-2994